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Background: For a long time mushrooms have been playing an important role in several aspects of the human
activity. Recently edible mushrooms are used extensively in cooking and make part of new food in Bangladesh for
their beneficial properties. The aim of this study is to screen some values of mushrooms used in Bangladesh.
Methods: Methanolic extracts of 3 edible mushrooms (Pleurotus ostreatus, Lentinula edodes, Hypsizigus tessulatus) isolated
from Chittagong, Bangladesh were used in this study. Phenolic compounds in the mushroom methanolic extracts were
estimated by a colorimetric assay. The antioxidant activity was determined by radical 1, 1-diphenyl;-2-picrylhydrazyl (DPPH)
radical scavenging assay. Eight microbial isolates were used for antimicrobial activity of methanolic extract of mushrooms
by the agar well diffusion method with slight modification.
Results: Determination of antimicrobial activity indicated considerable activity against all bacteria and fungi reveling zone
of inhibition ranged from 7 ± 0.2 to 20 ± 0.1 mm. Minimum inhibitory concentration values of the extracts showed that
they are also active even in least concentrations ranged from 1 mg/ml to 9 mg/ml. Lentinula edodes showed the best
antimicrobial activity than others. Pseudomonas aeruginosa was quite resistant and Saccharomyces cerevisiae was more
sensitive than others microbial isolates. Antioxidant efficiency by inhibitory concentration on 1,1-Diphenly-2-picrylhydrazyl
(DPPH) was found significant when compared to standard antioxidant like ascorbic Acid . The concentration (IC50)
ranged from 100 ± 1.20 to 110 ± 1.24 μg/ml. Total phenols are the major bioactive component found in extracts of
isolates expressed as mg of GAE per gram of fruit body, which ranged from 3.20 ± 0.05 to 10.66 ± 0.52 mg/ml. Average
concentration of flavonoid ranged from 2.50 ± 0.008 mg/ml to 4.76 ± 0.11 mg/ml; followed by very small concentration of
ascorbic acid (range, 0.06 ± 0.00 mg/ml to 0.21 ± 0.01 mg/ml) in all the isolates. All the isolates showed high phenol and
flavonoid content (except Pleurotus ostreatus), but ascorbic acid content was found in traces.
Conclusion: This study has revealed that selected edible mushrooms have not only nutritional values but also some
therapeutic values. Proper and more investigations can lead us to use these as strong medicine in future.Introduction
Mushrooms have become attractive as a functional food
and as a source for the development of drugs and nutra-
ceuticals [1]. Edible mushrooms are the fleshy and edible
fruit bodies of several species of macrofungi. Edibility may
be defined by criteria that include absence of poisonous ef-
fects on humans and desirable taste and aroma [2,3]. Ed-
ible mushrooms are consumed by humans as comestibles
for their nutritional value and they are occasionally* Correspondence: md.mehadihassanchy@yahoo.com
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unless otherwise stated.consumed for their supposed medicinal value. Mushrooms
consumed by those practicing folk medicine are known as
medicinal mushrooms [4].
Medicinal mushrooms are thought to be treatments
for diseases, yet remain unconfirmed in mainstream sci-
ence and medicine, and so are not approved as drugs or
medical treatments [5].
Preliminary research has shown some medicinal mush-
room isolates to have cardiovascular, anticancer, antiviral,
antibacterial, antiparasitic, anti-inflammatory, and antidia-
betic properties [6,7]. Currently, several extracts have
widespread use in Japan, Korea and China, as potential ad-
juvants to radiation treatments and chemotherapy [5,8].ntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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include anticancer, antibiotic, antiviral activities, im-
mune response stimulating effects and blood lipid low-
ering effects [9]. Both fruiting body and mycelium of
different mushrooms contain different compounds such
as terpenoids, steroids, polyphenol, polyketides, poly-
glucan, flavonoids, alkaloids, polysaccharides and diet-
ary fibers which exert several pharmacological activities
[10]. They are the rich source of antioxidants, antibi-
otics and antineoplastic activity [11].
The history of mushroom cultivation is not so long in
Bangladesh; however, mushroom consumption is in-
creasing rapidly in this country due to cheap source of
dietary protein, carbohydrate, vitamins and minerals. For
the medicinal and nutritional value, several species of
mushroom are being cultivated in Bangladesh [12].
These are reishi, enoki, oyster, shiitake, shimeji, milky,
beech and nameko etc. [13].
Hypsizygus tessulatus which is commonly known as
Shimeji mushroom contains glucans, niacin, vitamin B
and D. Vitamin B aids in immunity and weight loss,
while vitamin D is deemed to be effective against osteo-
porosis and anti-aging [14]. The previous name of this
mushroom was Hypsizygus marmoreus and it also con-
tain different biologically active compounds like polysac-
charides, l-ergothioneine, sterols, ergosterol - provitamin
D2 which have different medicinal uses [15-17].
Pleurotus ostreatus, the oyster mushroom, is a common
edible mushroom. The oyster mushroom may be consid-
ered a medicinal mushroom, since it contains statins such
as lovastatin which work to reduce cholesterol [18].
Lentinula edodes known as Shiitake is an edible mush-
room native to East Asia, which is cultivated and con-
sumed in many Asian countries. It is considered a
medicinal mushroom in some forms of traditional medi-
cine [19]. Studies there indicate prolonged survival and
improved quality of life when gastric cancer patients
with unrespectable or recurrent diseases are treated with
lentinan in combination with other chemotherapies [20].
The aim of this study was to evaluate the antibacterial,
cytotoxic and antioxidant properties of Hypsizygus tessu-
latus, Lentinula edodes and Pleurotus ostreatus different
extract both from submerged culture and mycelia mat.
Materials and method
Mushroom samples
Samples of P. ostreatus, Hypsizygus tessulatus, Lentinula
edodes were collected which were cultivated and sold as
edible mushrooms from Chittagong, Bangladesh. Identi-
fication was done by comparing their morphological,
anatomical and physiological characteristics and mono-
graphs with descriptions given in the manual [21]. Then
mushrooms were air-dried in a liophylizator before ana-
lysis. All the specimens were deposited at the herbariumof mycology laboratory, Department of Microbiology,
University of Chittagong, Chittagong, Bangladesh. The
fruiting bodies, carefully removed from the hyphae were
weighed then dried at 40°C for 24 h. The dried fruiting
body samples were weighed and ground into powder
prior to extraction.
Preparation of methanolic extracts
Preparation of methanolic extracts of mushrooms was
done based on procedures described by Barros et al. [22]
with some modifications. A fine-dried mushroom pow-
der sample (100 g) was extracted by stirring with 100 ml
of methanol at 25°C at 150 rpm for 24 hours and filtered
through Whatman no. 4 paper. The residue was then ex-
tracted with two additional 100-ml portions of methanol.
The combined methanolic extracts were evaporated at
40°C to dryness. The organic solvent in the extracts was
removed by a rotary evaporator. For the entire analysis,
compounds of extract were dissolved in dimethylsulfox-
ide (DMSO), and filter-sterilization was done through a
0.22-μm membrane filter. Extracts were kept in the dark
at 4°C for not more than 1 week prior to use.
Determination of bioactive components
Phenolic compounds in the mushroom methanolic ex-
tracts were measured by a colorimetric assay, wherein 1
ml of sample was mixed with 1 ml of Folin and Ciocal-
teu’s phenol reagent. After 3 minutes, 1 ml of saturated
sodium carbonate solution was added to the mixture
and adjusted to 10 ml with distilled water [22]. The reac-
tion was kept in the dark for 90 minutes, after which the
absorbance was measured spectrophotometrically at 765
nm. Gallic acid was used to calculate the standard curve
(0.01-0.4 mM). The mean values of results were
expressed as milligrams of gallic acid equivalents (GAEs)
per gram of extract.
Flavonoid concentrations were estimated [23], where in
methanolic extract solution (1 ml) was diluted with 4.3 ml
of 80% aqueous ethanol, and 0.1 ml of 10% aluminum ni-
trate and 0.1 ml of 1 M aqueous potassium acetate were
added. After 40 minutes at room temperature, the solution
was mixed well, and the intensity of the pink color was
measured spectrophotometrically (Model - UV-1601 SHI-
MADZU) at 415 nm. Quercetin was used to calculate the
standard curve of total flavonoid concentration absorb-
ance = 0.002108 μg quercetin – 0.01089 (R2: 0.9999).
Ascorbic acid was determined [22], where in methanolic
extract (100 mg) was extracted with 10 ml of 1% meta-
phosphoric acid for 45 minutes at room temperature and
filtered through Whatman no, 4 filter paper. The filtrate
(1 ml) was mixed with 9 ml of 2, 6-dichloroindophenol
(0.025%), and the absorbance was measured within 30 mi-
nutes at 515 nm against a blank. Content of ascorbic acid
was calculated on the basis of the calibration curve of
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were expressed as milligrams of ascorbic acid per milliliter
of extract. All the above estimations of bioactive com-
pounds were carried out in triplicate and means were
plotted.
Scavenging activity on DPPH for antioxidant assay
The antioxidant activity of the extracts on the stable rad-
ical 1, 1-diphenyl;-2-picrylhydrazyl (DPPH) was deter-
mined by the method developed by Feresin et al. (2002)
[24]. The 0.1 ml of mushroom ethanol extract, at various
concentrations was added to 3 ml of a 0.004% methanol
solution of DPPH and was allowed to stand for 30 min
for the reaction to occur. The absorbance of the result-
ing solution was measured at 517 nm from this values
the corresponding percentage of inhibitions were calcu-
lated by using the following equation:




Where, Ablank is the absorbance of the control reaction
(containing all reagents except the test sample) and
Asample is the absorbance of sample/standard.
Extract concentration providing 50% inhibition (IC50)
was calculated from the graph plotted I% versus concen-
tration curve. The free radical scavenging activity was
measured for different concentrations of sample and
compared with standard (Ascorbic acid).
Determination of antimicrobial efficacy
Microbial test organisms
The bacterial test organisms used were Staphylococcus
aureus (ATCC 25923), Bacillus subtilis (ATCC 6633) as
gram-positive species and Escherichia coli (ATCC
25922), Klebsiella pneumonia (ATCC 13883), Pseudo-
monas aeruginosa (ATCC 27853) and Salmonella typhi
(ATCC 33459) as gram-negative species grown in Muel-
ler Hinton agar at 37°C for 24 hours (Merck). Fungal
species was unicellular Candida albicans (ATCC 60192)
and Saccharomyces cerevisiae (ATCC 9763) grown in
potato dextrose agar (Hi Media) at ambient temperature
for 72 hours. The bacterial isolates were multidrug re-
sistant determined by disc diffusion assay according to
Iwalokun et al. [25].
Antibacterial and antifungal screening
Antimicrobial activity of methanolic extract of mush-
rooms was determined by the agar well diffusion method
[26], with slight modification to suit the conditions of
this experiment. Briefly, the methanol extracts were dis-
solved in 3% dimethylsulfoxide (DMSO) to a final con-
centration of 10 mg/ml, and filter sterilized through
0.45-μm membrane filter. Small wells (6 mm in diam-
eter) were made in the agar plates by sterile cork borer.One hundred microliters of the extract of each isolate of
mushrooms was loaded into the different wells. An over-
night culture of each microbial isolate was emulsified
with nutrient broth to a turbidity that was equivalent to
0.5 McFarland (108 cfu/ml). In order to determine the
antimicrobial efficacy of the fractions, aliquot of test cul-
ture (100 μl) was evenly spread over the surface of the so-
lidified agar. Bacteria were cultured on Mueller Hinton
agar; and fungi on potato dextrose agar. Ciprofloxacin
(5 μg/well) for bacteria, fluconazole (5 μg/well) for fungi
were used as positive control and DMSO was used as
negative control for test microorganisms. All the pre-
loaded plates with respective extract and test organism
were incubated at 37°C, for 24 hours for bacteria and at
27°C. 48 hours for fungi. After incubation period, zone of
inhibition was measured in millimeters. All the tests were
carried out in triplicate and their means recorded.Minimum inhibitory concentration (MIC)
The standard agar dilution protocol with doubling dilu-
tion was used. The extract was incorporated into nutri-
ent agar at concentrations ranging from 0.39 mg/ml to
25 mg/ml. A control without the extract was also pre-
pared. 10 μL of each test organisms, previously diluted
to 10 CFU/ml, were used to inoculate the plates. These
were incubated at 37°C for 24 h in the first instance and
for another 24 h before the growth was observed and re-
corded. The minimum inhibitory concentrations (MICs)
of the extract for each test microorganism were consid-
ered the agar plate with the lowest concentrations with-
out growth [27].Results
Antimicrobial
The present study has revealed the antibacterial and an-
tifungal activity of mushroom extract. The results of
antibacterial activity were presented in Table 1. All the
mushrooms also revealed antimicrobial activity showing
different MICs for each microorganism (Table 2).Antioxidental
In case of antioxidant screening of ethanol extract of Hyp-
sizygus tessulatus powdered mycelium has shown in
Table 3. The IC50 value, defined as the concentration of
antioxidant required for 50% scavenging of DPPH radicals
in this specified time period, is a parameter widely used to
measure antioxidant activity; a smaller IC50 value corre-
sponds to a higher antioxidant activity of the plant extract.
IC50 value of the ethanol extract was 105.0 μg ml
−1. These
values state that H. tessulatus has moderate DPPH scaven-
ging activity compared to Ascorbic acid standard.
Table 1 Preliminary antimicrobial testing of mushroom
extracts through determination of zone of inhibition
(mm ± SD)*







Staphylococcus aureus 13.5 ± 0.1 16 ± 0.2 14 ± 0.2 25 ± 0.2
Bacillus subtilis 14 ± 0.2 17 ± 0.2 16 ± 0.2 24 ± .01
Escherichia coli 11 ± 0 14 ± 0.1 12.5 ± 0.1 24 ± .01
Pseudomonas aeruginosa 7 ± 0.2 12 ± 0.2 9 ± 0.2 20 ± 0.1
Salmonella typhi 11.5 ± 0.3 15 ± 0.1 12.5 ± 0.1 20 ± 0.1
Klebsiella pneumoniae 9.7 ± .02 13 ± 0.1 11.5 ± 0.3 24 ± 0.1
Candida albicans 13.5 ± 0.1 18 ± 0.2 16 ± 0.2 25 ± 0.3
Saccharomyces cerevisiae 15 ± 0.2 20 ± 0.1 18 ± 0.2 30 ± 0.3
*The diameters of zone of inhibition were expressed in millimeter (mm) as
mean ± standard deviation (SD).
Table 3 Free radical scavenging activity (IC50μg/ml)
Sample Value
H. tessulatus Extract 105.0 ± 1.23
Pleurotus ostreatus Extract 100 ± 1.20
Lentinula edodes Extract 110 ± 1.24
Standard Ascorbic Acid 5.25 ± 0.21
The values of IC50 are expressed as Mean ± SEM (n = 3).
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Table 4 showed phenol, flavonoid and ascorbic acid con-
centrations of the isolates; total phenols were the major bio-
active component found in extracts of isolates expressed as
mg of GAE per gram of fruit body, which ranged from
10.66 ± 0.52 to 5.65 ± 0.05 mg/ml.
Discussion
Antimicrobial assay
All the mushrooms used in this study were found to ex-
hibit various degrees of antimicrobial effects against the
tested microorganisms. The zone of inhibition exhibited
more than 10 millimeters was considered as highly active
for extracts. P. ostreatus has a broad-spectrum antibac-
terial and antifungal activity. Similar antimicrobial poten-
tials have been observed in the culture extracts of Irpex
lacteus (Rosa et al., 2003), Agrocybe sp. (Kavanagh et al.,
1950; Mavoungou et al., 1987) [28-30]. The best in-vitro









Staphylococcus aureus 6 3 7
Bacillus subtilis 7 3 8
Escherichia coli 6 3 7
Pseudomonas aeruginosa 8 4 9
Salmonella typhi 5 2 7
Klebsiella pneumoniae 7 3 6
Candida albicans 4 1 6
Saccharomyces cerevisiae 4 1 5
Note. Each value is expressed as mean (n = 3) and standard deviations were
less than 5%.followed by Pleurotus ostreatus and Hypsizigus tessulatus
against Bacillus subtilis. Lentinula edodes also showed
best antimicrobial activity than Pleurotus ostreatus
and Hypsizigus tessulatus. This antimicrobial efficacy
of Lentinula edodes was similar of the study of Kuznetsov
et al., 2005 [31].
Ishikawa et al. (2001), reported data similar to the re-
sults obtained in this work, showing antibacterial action of
L. edodes against B. cereus, S. aureus and E.coli [32].
Komemushi et al. (1996) also reported that L. edodes inhib-
ited growth of Gram positive and Gram negative bacteria
[33]. The revealed information regarding strong antimicro-
bial activity of Hypsizigus tessulatus against pathogenic iso-
lates has similarity of the study of Hearst et al., 2009 [34].
Candida albicans and Saccharomyces cerevisiae was
found to be very susceptible when compared to positive
controls. Pseudomonas aeruginosa showed more resistant
to mushrooms extract comparatively than other isolates.
Among the bacterial isolates, The MIC of all mush-
rooms extract was high for Pseudomonas aeruginosa.
The MICs of Lentinula edodes against all isolates were
low comparatively others. The Lowest MIC was ob-
served for Candida albicans and Saccharomyces cerevi-
siae against Lentinula edodes. This quite similar result
was also observed by Barros et al., 2006 [35].
Antioxidantal
In the DPPH assay, the antioxidants are able to reduce
the stable DPPH radical (purple) to the non-radical form
DPPH-H (yellow). The DPPH scavenging activities of
antioxidants are attributed to their hydrogen donating
abilities. All the mushroom extract showed the antioxi-
dant activity. But the differentiation between the extract
is too close. Lentinula edodes showed the highest anti-
oxidant activity. This result is quite similar by Emanuel
Vamanu, 2012 [36].Table 4 Bioactive compound contents of the wild edible









H. tessulatus 5.65 ± 0.05 2.50 ± 0.008 0.11 ± .01
Pleurotus ostreatus 3.20 ± 0.05 00 0.06 ± 0.00
Lentinula edodes 10.66 ± 0.52 4.76 ± 0.11 0.21 ± 0.01
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also quite similar by Arbaayah HH And Umi Kalsom Y,
2013 [37].
Bioactive components
Flavonoids, which are also phenolic compounds, were
not detected in P. ostreatus. Our observation agrees with
findings of Mattila et al., 2001 [38] and according to
USDA, mushrooms are regarded as non-sources of fla-
vonoids. Higher contents of bioactive compounds were
found in Lentinula edodes. This statement is too similar
to the experiment by Calhelha et al., 2007 [22]. The
amount of phenolic contents and Flavonoids from
H. tessulatus was moderate and similar by the study of
Monira et al., 2012 [39].
Conclusion
The present investigation can conclude that the metha-
nolic extract of 3 edible mushrooms showed biopharma-
ceutical potentiality. However whether such extracts will
act as effective therapeutic agents remain to be investi-
gated, the identification of the bioactive compounds and
study of mechanisms of actions are necessary prior to
application.
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